Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-07 Sale | 2024-03-11 6:21 pm | Blueprint Medicines Corp | BPMC | Rossi Christina CHIEF OPERATING OFFICER | 6,070 | $90.69 | $550,488 | 64,306 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 9:36 pm | Blueprint Medicines Corp | BPMC | Rossi Christina CHIEF OPERATING OFFICER | 3,059 | $45.67 | $139,715 | 55,376 (Direct) | View |
| 2022-11-03 Sale | 2022-11-07 4:08 pm | Blueprint Medicines Corp | BPMC | Rossi Christina CHIEF OPERATING OFFICER | 533 | $45.24 | $24,113 | 43,435 (Direct) | View |
| 2021-11-03 Sale | 2022-03-23 4:05 pm | Blueprint Medicines Corp | BPMC | Rossi Christina CHIEF COMMERCIAL OFFICER | 511 | $110.85 | $56,644 | 43,968 (Direct) | View |
| 2022-03-03 Sale | 2022-03-08 4:05 pm | Blueprint Medicines Corp | BPMC | Rossi Christina CHIEF COMMERCIAL OFFICER | 2,244 | $58.37 | $130,986 | 44,479 (Direct) | View |
| 2021-03-04 Sale | 2021-03-05 5:48 pm | Blueprint Medicines Corp | BPMC | Rossi Christina Chief Commercial Officer | 1,359 | $86.77 | $117,920 | 31,723 (Direct) | View |
| 2020-11-03 Sale | 2020-11-05 5:02 pm | Blueprint Medicines Corp | BPMC | Rossi Christina Chief Commercial Officer | 345 | $99.69 | $34,393 | 20,020 (Direct) | View |
| 2020-03-09 Sale | 2020-03-11 4:27 pm | Blueprint Medicines Corp | BPMC | Rossi Christina Chief Commercial Officer | 135 | $51.96 | $7,015 | 20,365 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Option Award | 2024-07-08 7:07 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Rossi Christina CHIEF OPERATING OFFICER | 9,625 | $0 | 73,931 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:30 pm | N/A 2034-06-13 | Xilio Therapeutics Inc. | XLO | Rossi Christina Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-06 4:20 pm | N/A 2034-03-01 | Blueprint Medicines Corp | BPMC | Rossi Christina CHIEF OPERATING OFFICER | 45,000 | $0 | 100,376 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 4:30 pm | N/A 2033-06-11 | Xilio Therapeutics Inc. | XLO | Rossi Christina Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:07 pm | N/A 2033-03-01 | Blueprint Medicines Corp | BPMC | Rossi Christina CHIEF OPERATING OFFICER | 45,000 | $0 | 88,435 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:30 pm | N/A 2032-06-14 | Xilio Therapeutics Inc. | XLO | Rossi Christina Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 8:08 pm | N/A 2032-03-01 | Blueprint Medicines Corp | BPMC | Rossi Christina CHIEF COMMERCIAL OFFICER | 45,000 | $0 | 76,723 (Direct) | View |
Ownership | 2021-10-21 8:38 pm | N/A 2031-06-16 | Xilio Therapeutics Inc. | XLO | Rossi Christina Director | 0 | $0 | 53,213 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:27 pm | N/A 2031-03-01 | Blueprint Medicines Corp | BPMC | Rossi Christina Chief Commercial Officer | 39,187 | $0 | 59,207 (Direct) | View |
| 2020-03-01 Option Award | 2020-03-03 7:11 pm | N/A 2030-03-01 | Blueprint Medicines Corp | BPMC | Rossi Christina Chief Commercial Officer | 42,750 | $0 | 49,000 (Direct) | View |